Please assess the completion status of the following clinical trial:

Trial Title: Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With Eczema

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Able to comprehend and follow the requirements of the study (including availability on scheduled visit dates)~2. Male or female of any race or ethnicity, ages 12 and older~3. Diagnosed as having eczema~4. Willing to stop use of all non-assigned moisturizers and/or creams for the entire duration of the study~Exclusion Criteria:~1. Known sensitivity to any investigational product ingredient~2. Females who are pregnant , breastfeeding , or planning on becoming pregnant during the study~3. Individuals with a history of skin cancer~4. Use of a therapeutic (over-the-counter or prescription) body wash that contains an active ingredient for eczema~5. Participation in any clinical study within 30 days of Visit 1~6. Active infection of any type at the start of the study~7. Diagnosed as having severe eczema~8. Has a compromised immune system~9. Individuals with any planned surgeries and/or invasive medical procedures during the course of the study~10. Requires greater than 2.0mg/day inhaled or intranasal corticosteroids

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Positive Control (Type: ACTIVE_COMPARATOR): Marketed - EpiCeram(R) Skin Barrier Emulsion: Apply in a thin layer to the affected skin areas 2 times per day (or as needed) and massage gently into the skin.
- Experimental (Type: EXPERIMENTAL): Not Yet Marketed - 1% Colloidal Oatmeal Balm: Apply at least once per night or more if needed.

Based on this trial design, predict the completion outcome and termination type (if applicable).